Your session is about to expire
← Back to Search
Behavioral Intervention
Health Through Activity Program for Multiple Myeloma
N/A
Waitlist Available
Led By Kathleen Lyons, ScD, OTR/L
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥18 years of age
Diagnosed with multiple myeloma currently receiving maintenance therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 months
Awards & highlights
Study Summary
This trial will test if a structured program can help improve quality of life for people with multiple myeloma.
Who is the study for?
This trial is for adults over 18 with multiple myeloma who are on maintenance therapy and find their daily or social activities limited by health problems. It's not suitable for those with new or uncontrolled bone pain, recent fractures without repair, conditions preventing safe exercise, or moderate to severe cognitive impairment.Check my eligibility
What is being tested?
The study tests the 'Health Through Activity' program, which includes a six-session rehabilitation exercise regimen designed to improve physical function and quality of life in people living with multiple myeloma.See study design
What are the potential side effects?
Since this intervention involves an exercise program tailored to individuals with multiple myeloma, potential side effects may include muscle soreness, fatigue, and increased risk of injury if exercises are not performed correctly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am currently on maintenance therapy for multiple myeloma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment Completion Rate
Eligibility Rate
Rate of Participant Enrollment
+1 moreSecondary outcome measures
Intervention Completion Rate
Participant Satisfaction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Health Through Activity (HTA) InterventionExperimental Treatment1 Intervention
Participants will undergo study procedures as outlined:
Complete a baseline survey regarding activity level and quality of life.
Attend 6 weekly study visits at the MGH Institute of Health Professions IMPACT Practice Center.
Attend final study visit and complete the Satisfaction survey and an individual, semi-structured interview with site staff to supply feedback about the program.
After six weeks, complete the Satisfaction survey again.
Find a Location
Who is running the clinical trial?
MGH Institute of Health ProfessionsLead Sponsor
15 Previous Clinical Trials
3,635 Total Patients Enrolled
Kathleen Lyons, ScD, OTR/LPrincipal InvestigatorMassachusetts General Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had a bone break in the last year that didn't need surgery.I have new or worsening bone pain that greatly affects my daily life.I don't have any health issues that prevent me from safely exercising.I am 18 years old or older.You have significant problems with memory and thinking, as shown by a low score on a cognitive screening test.I am currently on maintenance therapy for multiple myeloma.My health issues prevent me from doing daily or social activities.
Research Study Groups:
This trial has the following groups:- Group 1: Health Through Activity (HTA) Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any new participants being sought for this experiment?
"Unfortunately, the trial previously listed on clinicaltrials.gov is no longer recruiting participants; it was first posted on February 1st 2023 and last updated 17th January of the same year. However, 806 other studies have opened recruitment in its stead."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger